CLOV Clover Health Investments, Corp.
CLOV Clover Health Investments, Corp.
Healthcare · Healthcare Plans
Market read
Scan convergence 1 scan as of 2026-10-23 1 bull converging
POC $2.50 · VWAP $3.36 · +36.9% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster CEO, CFO + 3 others sold $694.3K, Oct 7–20
CLOV Price Structure
Loading timeframes…
Decision history
2 scored calls · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
Reported the quarter ending 2026-06-30: revenue $743M, diluted EPS $0.05, net income $28M (SEC filing). Across the print the stock moved +9.1% (close before → first close after).
full note →Against street estimates
How CLOV's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
CLOV research tape
77 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.